24486-801 : Cefditoren Pivoxil 200 mg Oral Tablet
NDC: | 24486-801 |
Labeler: | Aristos Phamaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Cefditoren Pivoxil |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA021222 |
Rev. Date: |
Appearance:
Markings: | CBP;200 |
Shapes: |
Oval |
Colors: |
White |
Size (mm): | 17 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 24486-801-20: 20 TABLET, FILM COATED IN 1 BLISTER PACK (24486‑801‑20)
Active Ingredients:
- Cefditoren Pivoxil
Dosage Strength:
- 200 mg
Inactive Ingredients:
- Carnauba Wax
- Croscarmellose Sodium
- D&c Red No. 27
- Mannitol
- Fd&c Blue No. 1
- Hydroxypropyl Cellulose
- Hypromelloses
- Magnesium Stearate
- Polyethylene Glycols
- Propylene Glycol
- Shellac
- Sodium Caseinate
- Sodium Tripolyphosphate
- Titanium Dioxide
Pharmaceutical Classes:
- Cephalosporin Antibacterial [EPC]
- Cephalosporins [Chemical/Ingredient]
Related Products:
Based on records with the same trade name.- 24486-802 Cefditoren Pivoxil 400 mg Oral Tablet by Aristos Phamaceuticals, Inc.
- 44009-801 Cefditoren Pivoxil 200 mg Oral Tablet by Pharma Romlev Inc.
- 44009-802 Cefditoren Pivoxil 400 mg Oral Tablet by Pharma Romlev Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 24486-200Next: 24486-802 >
Related Discussions:
cefditoren
MODE OF ACTION, HOW AND WHERE TO Rx AND WHERE TO NOT , SIDE EFFECT, CLINICAL EFFICACY....
MODE OF ACTION, HOW AND WHERE TO Rx AND WHERE TO NOT , SIDE EFFECT, CLINICAL EFFICACY....
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.